|
| 37423228 | First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study. | Lancet | 2023 |
| 36450379 | Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer. | J Immunother Cancer | 2022 |
| 30692535 | Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors. | Nat Commun | 2019 |
| 30559362 | Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors. | Nat Commun | 2018 |
| 30497530 | Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. | Genome Med | 2018 |
| 28915659 | Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity. | Oncotarget | 2017 |
| 28487444 | The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer. | Clin Cancer Res | 2017 |
| 28356166 | Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome. | Breast Cancer Res | 2017 |
| 29089486 | Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors. | Nat Commun | 2017 |
| 27161491 | The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. | Nat Commun | 2016 |
| 27264733 | Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. | Nat Commun | 2016 |
| 25169931 | A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer. | Mol Oncol | 2015 |
| 26460974 | The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer. | PLoS One | 2015 |
| 26400872 | Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors. | Endocr Relat Cancer | 2015 |
| 25882602 | Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF. | Breast Cancer Res | 2015 |
| 25873999 | Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer. | Genome Med | 2015 |
| 25351767 | Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53. | Mol Cancer Res | 2015 |
| 24388359 | The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors. | Mol Oncol | 2014 |
| 25407022 | Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study. | BMC Cancer | 2014 |
| 24803582 | TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance. | Clin Cancer Res | 2014 |
| 24759209 | Principles and methods of integrative genomic analyses in cancer. | Nat Rev Cancer | 2014 |
| 24937458 | JARID1B is a luminal lineage-driving oncogene in breast cancer. | Cancer Cell | 2014 |
| 24633157 | Recurrent PTPRB and PLCG1 mutations in angiosarcoma. | Nat Genet | 2014 |
| 24645668 | Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status. | BMC Cancer | 2014 |
| 23253899 | The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells. | Mol Oncol | 2013 |
| 23920327 | Triple-negative breast cancer and the need for new therapeutic targets. | Am J Pathol | 2013 |
| 23596205 | Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer. | Sci Transl Med | 2013 |
| 23671412 | Improving breast cancer survival analysis through competition-based multidimensional modeling. | PLoS Comput Biol | 2013 |
| 22130873 | Analyzing cancer samples with SNP arrays. | Methods Mol Biol | 2012 |
| 23442169 | Copynumber: Efficient algorithms for single- and multi-track copy number segmentation. | BMC Genomics | 2012 |
| 21917534 | Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. | Mol Oncol | 2011 |
| 22128823 | The breast cancer genome--a key for better oncology. | BMC Cancer | 2011 |
| 20592421 | Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. | Sci Transl Med | 2010 |
| 20688275 | The importance of gene-centring microarray data. | Lancet Oncol | 2010 |
| 21082043 | Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2. | Neoplasia | 2010 |